top
Search terms
Results 51 - 60 of 204 - ordered by :
Pages: 1 ... 3 4 5 6 7 8 9 ... 21
Epeuropace

Abstract The purpose of this EP Wire survey was to assess clinical practice in periprocedural management of atrial fibrillation ablation. Procedure-related complications in various groups of ...

Europace, EP WIRE, Jian Chen, Derick M. Todd, Mélèze Hocini, Torben Bjerregaard Larsen, Maria Grazia Bongiorni, Carina Blomström-Lundqvist, Conducted by the Scientific Initiative Committee, ...

Date : 01/03/2014 Item size : 161332 bytes
Epeuropace

A second procedure achieved isolation of three pulmonary veins and showed persistence of pulmonary vein tachycardia in one with implications concerning the electrophysiology of atrial fibrillation. ...

Europace, Case Report, Pepijn H. van der Voort, Albert Meijer

Date : 01/11/2004 Item size : 120670 bytes
Epeuropace

Recurrence of AF is defined as any documented AF episode >30 s. Acute procedural results show that 692 veins were acutely isolated with a mean procedure and fluoroscopy time of 226 and 20.4 min, ...

Europace, CLINICAL RESEARCH, Lucie Šedivá, Jan Petrů, Jan Škoda, Marek Janotka, Milan Chovanec, Vivek Reddy, Petr Neužil

Date : 01/12/2014 Item size : 206985 bytes
Epeuropace

The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) Trial: clinical rationale, study design, and implementation Abstract Aims No large ...

Europace, Christian Jons, Peter Steen Hansen, Arne Johannessen, Gerhard Hindricks, Pekka Raatikainen, Ole Kongstad, HÃ¥kan Walfridsson, Steen Pehrson, Henrik Almroth, Juha Hartikainen, Anders ...

Date : 01/07/2009 Item size : 180817 bytes
Epeuropace

Abstract Aims Intravenous adenosine triphosphate (ATP) administration could reveal dormant conduction (DC) gaps on the ablation line of a pulmonary vein isolation (PVI). The DC sites at each of the ...

Europace, CLINICAL RESEARCH, Kazuaki Kaitani, Toshiya Kurotobi, Atsushi Kobori, Katsunori Okajima, Takenori Yao, Yuko Nakazawa, Yoshihisa Nakagawa

Date : 01/04/2014 Item size : 240492 bytes
Epeuropace

[...]the diagnosis of the complication often is delayed because of the significant time delay of its occurrence after the ablation procedure (which mostly is 14 weeks) and unspecific initial ...

Europace, Editorial, Philipp Sommer, Gerhard Hindricks

Date : 01/07/2010 Item size : 149951 bytes
Epeuropace

In this issue of the Journal, Bänsch et al.4 tested the hypothesis that waiting after successful isolation of the pulmonary veins and treating reconnection that occurred during the waiting time ...

Europace, Editorial, Joris R. de Groot

Date : 01/02/2013 Item size : 142211 bytes
Epeuropace

Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice, and is associated with substantial mortality and morbidity due to stroke and heart failure.1 It ...

Europace, Editorial, Chung-Wah Siu, Hung-Fat Tse

Date : 01/06/2010 Item size : 132476 bytes
Epeuropace

The most recent European Society of Cardiology guidelines state that left atrial ablation should be considered (Class IIa recommendation) for symptomatic patients with either paroxysmal or persistent ...

Europace, Editorial, Bart Hooft van Huysduynen, Michiel Rienstra

Date : 01/05/2012 Item size : 139997 bytes
Epeuropace

Abstract The use of adenosine in unmasking potential trigger' activity in a patient with paroxysmal atrial fibrillation (AF) and persistent left superior vena cava (LSVC) has never been ...

Europace, Short Communication, François Regoli, Santi Raffa, Anett Große, Michele Brunelli, J. Christoph Geller

Date : 01/01/2010 Item size : 124314 bytes